Xalkori approved for rare genetic form of lung cancer
Friday, March 11, 2016 - 16:40
in Health & Medicine
HealthDay News Xalkori has been approved by the U.S. Food and Drug Administration to treat advanced non-small cell lung cancer with tumors that have a rare gene mutation.